
Novel BRAF-Inhibitor Cream Ameliorates Rash From EGFR …
2021年4月28日 · For 6 of the 10 patients, the acneiform rash improved, say the investigators, led by Mario Lacouture, MD, Memorial Sloan Kettering Cancer Center, New York City. The study was published online ...
Gefitinib and Tyrosine Kinase Inhibitors: Cancer Therapy - Page 9
Rash occurred in 49% of patients in the lung cancer clinical trials. [2] The rash is a generalized acneiform type that most commonly occurs on the face and chest, but can occur anywhere on the ...
Acneiform Eruptions More Severe With Targeted Therapy Combos …
2022年6月3日 · Overall, 105 patients (86%) developed a rash and 87 (71%) developed an acneiform eruption. Seventy-five patients (61%) underwent subsequent dose modifications. The median time from treatment ...
Acne in a Patient With Pancreatic Cancer - Page 2 - Medscape
2009年5月18日 · Rash. A characteristic acneiform rash develops in about 60% to 80% of those on EGFR inhibitors. [ 5 ] The rash typically resembles acne and/or folliculitis and is usually most prominent on the ...
Acne in a Patient With Pancreatic Cancer - Page 5 - Medscape
2009年5月18日 · Wednesday, February 5, 2025. News & Perspective Drugs & Diseases CME & Education Video Drugs & Diseases CME & Education Video
What to Know About JAKne — JAK Inhibitor-Associated Acne
2024年8月22日 · Janus kinase (JAK) inhibitor-associated acne may be overlooked outside of dermatology, experts said.
Laser Treatment for Acne: Results From a Series of 100 Patients
2024年8月30日 · CARLSBAD, Calif. — After Arash Moradzadeh, MD, treated the first 100 consecutive patients in his practice with a 1726-nm laser (AviClear) following its Food and Drug Administration (FDA ...
Managing the Side Effects of PIK3CA and mTOR Inhibitors
2024年8月7日 · If rash is acneiform, treatment may include topical benzoyl peroxide, topical antibiotics such as clindamycin, and, if severe, oral antibiotics and/or systemic retinoids.
Diet and Skin: What is the Evidence? - Medscape
2024年1月22日 · ORLANDO — Amid all the hype, claims, and confusion, there is evidence linking some foods and drinks to an increased risk for acne, psoriasis, atopic dermatitis, rosacea, and other common skin ...
Dabrafenib-Trametinib Combo Approved for Pediatric Gliomas
2023年3月17日 · Dabrafenib/trametinib is the first systemic therapy approved for frontline treatment of low-grade, BRAF-mutated pediatric gliomas, the FDA said. The combination was approved in June 2022 for adult ...